2023 Q1 Form 10-K Financial Statement

#000109181823000033 Filed on March 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $196.4K $434.2K
YoY Change 282.4% 371.71%
Operating Profit -$196.4K -$434.2K
YoY Change 282.4% 371.71%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $3.000K $12.00K
YoY Change 0.0% 0.0%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$196.4K -$434.2K
YoY Change 282.4% 371.71%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 87.48M shares 87.48M shares 87.46M shares
Diluted Shares Outstanding 93.86M shares 87.46M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.236K $1.284K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $5.725K
Receivables
Other Receivables
Total Short-Term Assets $6.961K $1.284K
YoY Change -24.47%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $6.961K $1.284K
Total Long-Term Assets $0.00 $0.00
Total Assets $6.961K $1.284K
YoY Change -24.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.210K $403.2K
YoY Change 3820.03%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.210K $403.2K
Total Long-Term Liabilities
Total Liabilities $2.210K $403.2K
YoY Change 3820.03%
SHAREHOLDERS EQUITY
Retained Earnings -$830.1K -$633.7K
YoY Change 217.59%
Common Stock $231.1K $87.48K
YoY Change 0.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.751K -$401.9K
YoY Change
Total Liabilities & Shareholders Equity $6.961K $1.284K
YoY Change -24.47%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$196.4K -$434.2K
YoY Change 282.4% 371.71%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$48.00 -$40.29K
YoY Change -99.73% -12.33%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $39.88K
YoY Change -13.24%
NET CHANGE
Cash From Operating Activities -$48.00 -$40.29K
Cash From Investing Activities
Cash From Financing Activities $39.88K
Net Change In Cash -$48.00 -$416.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$48.00 -$40.29K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000894501
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 us-gaap Revenues
Revenues
usd
CY2021 us-gaap Revenues
Revenues
usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022 us-gaap Gross Profit
GrossProfit
usd
CY2021 us-gaap Gross Profit
GrossProfit
usd
CY2022 grhi Common Shares Issued For Consulting
CommonSharesIssuedForConsulting
usd
CY2022 grhi Common Shares Issued For Consulting1
CommonSharesIssuedForConsulting1
usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2022 us-gaap Interest Paid
InterestPaid
usd
CY2021 us-gaap Interest Paid
InterestPaid
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Entity Registrant Name
EntityRegistrantName
GOLD ROCK HOLDINGS, INC
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0434297
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
2020 General Booth Blvd
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Virginia Beach
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-56304
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23454
CY2022 dei City Area Code
CityAreaCode
(757)
CY2022 dei Local Phone Number
LocalPhoneNumber
306-6090
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
1153114 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
87482208 shares
CY2022 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1284 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1700 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1284 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1700 usd
CY2022Q4 us-gaap Assets
Assets
1284 usd
CY2021Q4 us-gaap Assets
Assets
1700 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
372175 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9285 usd
CY2022Q4 grhi Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
31000 usd
CY2021Q4 grhi Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
1000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
403175 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10285 usd
CY2022Q4 us-gaap Liabilities
Liabilities
403175 usd
CY2021Q4 us-gaap Liabilities
Liabilities
10285 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87482208 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87482208 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87382208 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87382208 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
87482 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
87382 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
144353 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103577 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
3700 usd
CY2021 grhi Capital Contributions Director
CapitalContributionsDirector
45959 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-633726 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-199544 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-401891 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8585 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1284 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1700 usd
CY2022 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
30000 usd
CY2021 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
30000 usd
CY2022 grhi Consulting Fees Expenses
ConsultingFeesExpenses
362500 usd
CY2021 grhi Consulting Fees Expenses
ConsultingFeesExpenses
12000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41682 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50044 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
434182 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
92044 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-434182 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-92044 usd
CY2022 grhi Weighted Average Number Of Common Shares Basic And Diluted
WeightedAverageNumberOfCommonSharesBasicAndDiluted
87461386 shares
CY2021 grhi Weighted Average Number Of Common Shares Basic And Diluted
WeightedAverageNumberOfCommonSharesBasicAndDiluted
78181056 shares
CY2022 grhi Net Loss For Period Per Common Shares Basic And Diluted
NetLossForPeriodPerCommonSharesBasicAndDiluted
-0.00
CY2021 grhi Net Loss For Period Per Common Shares Basic And Diluted
NetLossForPeriodPerCommonSharesBasicAndDiluted
-0.00
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-434182 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-92044 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1000 usd
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
3700 usd
CY2021 grhi Common Shares Issued For Consulting
CommonSharesIssuedForConsulting
3000 usd
CY2021 grhi Common Shares Issued For Consulting1
CommonSharesIssuedForConsulting1
29000 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-100 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
362890 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9285 usd
CY2022 grhi Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
-30000 usd
CY2021 grhi Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
-1000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40292 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45959 usd
CY2022 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
39876 usd
CY2021 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
45959 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39876 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45959 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-416 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1700 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1700 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1284 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1700 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-102200 usd
CY2021 grhi Common Stock Issued For Accrued Expenses Directors Fees
CommonStockIssuedForAccruedExpensesDirectorsFees
104000 usd
CY2021 grhi Common Stock Issued For Consulting And Director Compensation
CommonStockIssuedForConsultingAndDirectorCompensation
32000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-92044 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8585 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8585 usd
CY2022 grhi Capital Contributions Director
CapitalContributionsDirector
39876 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-434182 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-401891 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zT8BUnSCLBZ5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zxmYmQpF3GH8">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-633726 usd
CY2022Q4 grhi Working Capital
WorkingCapital
401891 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87482208 shares
CY2022 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
39876 usd
CY2021 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
45959 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
39876 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
45959 usd
CY2022 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
1000 usd
CY2022 us-gaap Other Expenses
OtherExpenses
12000 usd
CY2021 us-gaap Other Expenses
OtherExpenses
12000 usd
CY2022Q4 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
21000 usd
CY2021Q4 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
9000 usd
CY2022 us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
The Company had a 5 year compensation agreement with its Board Chairman beginning January 1, 2022 and ending on December 31, 2026. Compensation is an annual fee of $30,000, due in the following month of January.
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
30000 usd
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
30000 usd
CY2022Q4 grhi Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
31000 usd
CY2021Q4 grhi Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
1000 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87482208 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87382208 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87382208 shares
CY2022 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
100000 shares
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
grhi-20221231_pre.xml Edgar Link unprocessable
grh2722form10Kdec2022_htm.xml Edgar Link completed
0001091818-23-000033-index-headers.html Edgar Link pending
0001091818-23-000033-index.html Edgar Link pending
0001091818-23-000033.txt Edgar Link pending
0001091818-23-000033-xbrl.zip Edgar Link pending
ex103.htm Edgar Link pending
ex104.htm Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
grh2722form10Kdec2022.htm Edgar Link pending
grhi-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
grhi-20221231_cal.xml Edgar Link unprocessable
grhi-20221231_def.xml Edgar Link unprocessable
grhi-20221231_lab.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending